A multicenter study led by UC Davis Health has tested a new treatment designed to improve care for people with a rare liver ...
In a randomized clinical trial, vixarelimab demonstrates dose-dependent, long-term safety and efficacy in patients with ...
A new monoclonal antibody called nebokitug offers fresh hope to patients who have primary sclerosing cholangitis (PSC), ...
The 30th European Hematology Association (EHA) Congress (EHA 2025), held in Milan, Italy, from June 12-15, 2025, continued ...
Breakthroughs, discoveries, and DIY tips sent every weekday. Terms of Service and Privacy Policy. On Monday evening, the Food and Drug Administration announced that ...
A new monoclonal antibody treatment has shown promising results for a rare liver disease called primary sclerosing ...
A new artificial intelligence model could help design antibodies that better protect the body against viruses and disease.
As access to COVID-19 vaccines dwindles in the US, one company seems to be positioning its products as an alternative way of preventing the disease. Invivyd is the manufacturer of pemivibart, a ...
RA patients positive for anti-EBV EA-DR IgG antibodies show higher ACPA levels and increased disease activity, suggesting a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback